Association between Polygenic Risk Score and One-Year Outcomes Following As-Needed Aflibercept Therapy for Exudative Age-Related Macular Degeneration

• Главные авторы: Taiyo Shijo (Автор), Yoichi Sakurada (Автор), Seigo Yoneyama (Автор), Wataru Kikushima (Автор), Atsushi Sugiyama (Автор), Mio Matsubara (Автор), Yoshiko Fukuda (Автор), Fumihiko Mabuchi (Автор), Kenji Kashiwagi (Автор)
• Формат: ‌
• Опубликовано: MDPI AG, 2020-09-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

We investigated whether polygenic risk score (PRS) was associated with one-year outcome of as-needed aflibercept therapy for exudative age-related macular degeneration (AMD), including AMD (<i>n</i> = 129) and polypoidal choroidal vasculopathy (<i>n</i> = 132). A total of 261...